Keyphrases
Kidney Transplant Recipients
92%
Low Immunogenicity
50%
Kidney Transplantation
49%
Interstitial Fibrosis
40%
Tubular Atrophy
37%
COVID-19
37%
Subclinical Inflammation
34%
Inflammation
27%
Surveillance Biopsy
27%
Kidney Transplant
25%
Tacrolimus
25%
Renal Transplant
25%
Renal Function
23%
Focal Segmental Glomerulosclerosis
22%
Immunosuppression
21%
Renal Allograft Biopsy
16%
Primary Focal Segmental Glomerulosclerosis
16%
Indication Biopsy
15%
Clinical Significance
15%
Fibrosis
15%
Confidence Interval
14%
Transplantation
14%
Pathological Lesions
14%
Clinical Practice
13%
Graft Outcome
13%
Acute Rejection
13%
Borderline Changes
12%
Between-group
12%
Group Studies
12%
Viremic
12%
Gene Expression Score
12%
Renal Transplant Biopsies
12%
Mortality Reduction
12%
Lenvatinib
12%
Specific Analysis
12%
Cause-specific
12%
Hepatitis C Virus
12%
Diagnostic Algorithm
12%
Renal Transplantation
12%
Transcriptome Analysis
12%
Asymptomatic Bacteriuria
12%
Corticosteroid Withdrawal
12%
Treatment Optimization
12%
Apolipoprotein A-I (ApoA-I)
12%
Borderline Lesions
12%
Antibiotic Treatment
12%
Human Leukocyte Antigen
12%
Relative Bioavailability
12%
Once-daily Tacrolimus Formulation
12%
Renal Transplant Recipients
12%
Medicine and Dentistry
Kidney Graft
100%
Kidney Transplantation
66%
Biopsy Technique
59%
Immunosuppressive Treatment
45%
Idiopathic Pulmonary Fibrosis
39%
COVID-19
37%
Transplantation
34%
Focal Segmental Glomerulosclerosis
25%
Kidney Function
23%
Thymocyte Antibody
22%
Recurrent Disease
15%
Fibrosis
15%
Tacrolimus
14%
Diagnosis
13%
Biological Marker
13%
Asymptomatic Bacteriuria
12%
Apolipoprotein A
12%
Hepatitis C Virus
12%
Antibiotic Therapy
12%
Gene Expression Profiling
12%
Gene Expression
12%
Outpatient
12%
Solid Organ Transplantation
12%
Retrospective Cohort Study
12%
Kidney Allograft
11%
Proteinuria
10%
Infection
9%
Pyelonephritis
8%
Creatinine
8%
Population
8%
Basiliximab
6%
Humoral Rejection
6%
Graft Failure
5%
Drug Interaction
5%
Renal Biopsy
5%
Antivirus Agent
5%
Pharmacology, Toxicology and Pharmaceutical Science
Tacrolimus
25%
Disease
19%
Coronavirinae
18%
Infection
16%
Thymocyte Antibody
12%
Lenvatinib
12%
Hepatitis C Virus
12%
Biological Marker
12%
Focal Glomerulosclerosis
12%
Asymptomatic Bacteriuria
12%
Fibrosing Alveolitis
12%
Remdesivir
12%
Bioavailability
12%
Cardiovascular Disease
12%
Radioactive Iodine
12%
Differentiated Thyroid Cancer
12%
Adverse Event
9%
Pyelonephritis
8%
Acute Kidney Failure
7%
Mortality Rate
7%
Basiliximab
6%
Adult Respiratory Distress Syndrome
6%
Comorbidity
6%
Antivirus Agent
5%